BG21609A3 - Метод за получаване на заместени бензинпеницилини - Google Patents

Метод за получаване на заместени бензинпеницилини

Info

Publication number
BG21609A3
BG21609A3 BG021665A BG2166572A BG21609A3 BG 21609 A3 BG21609 A3 BG 21609A3 BG 021665 A BG021665 A BG 021665A BG 2166572 A BG2166572 A BG 2166572A BG 21609 A3 BG21609 A3 BG 21609A3
Authority
BG
Bulgaria
Prior art keywords
benzinepenicillins
obtaining substituted
substituted
obtaining
substituted benzinepenicillins
Prior art date
Application number
BG021665A
Other languages
English (en)
Inventor
Hans Koenig
Wilfried Schroeck
Karl Metzger
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG21609A3 publication Critical patent/BG21609A3/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
BG021665A 1971-10-23 1972-10-19 Метод за получаване на заместени бензинпеницилини BG21609A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (de) 1971-10-23 1971-10-23 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
BG21609A3 true BG21609A3 (bg) 1976-07-20

Family

ID=5823251

Family Applications (2)

Application Number Title Priority Date Filing Date
BG024757A BG20813A3 (bg) 1971-10-23 1972-10-19 Метод за получаване на заместени бензилпеницилини
BG021665A BG21609A3 (bg) 1971-10-23 1972-10-19 Метод за получаване на заместени бензинпеницилини

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG024757A BG20813A3 (bg) 1971-10-23 1972-10-19 Метод за получаване на заместени бензилпеницилини

Country Status (31)

Country Link
JP (2) JPS57843B2 (bg)
AR (1) AR195805A1 (bg)
AT (1) AT320152B (bg)
BE (1) BE790440A (bg)
BG (2) BG20813A3 (bg)
CA (1) CA1019323A (bg)
CH (1) CH579089A5 (bg)
CS (1) CS188883B2 (bg)
CY (1) CY947A (bg)
DD (1) DD106044B3 (bg)
DE (1) DE2152967C3 (bg)
DK (1) DK134992C (bg)
EG (1) EG10826A (bg)
ES (1) ES407851A1 (bg)
FI (1) FI56839C (bg)
FR (1) FR2157908B1 (bg)
GB (1) GB1392849A (bg)
HK (1) HK18578A (bg)
HU (1) HU167986B (bg)
IE (1) IE37123B1 (bg)
IL (1) IL40628A (bg)
KE (1) KE2824A (bg)
LU (1) LU66332A1 (bg)
NO (1) NO143909C (bg)
PH (1) PH9893A (bg)
PL (2) PL89056B1 (bg)
RO (2) RO60670A (bg)
SE (1) SE412236B (bg)
SU (1) SU527139A3 (bg)
YU (1) YU264072A (bg)
ZA (1) ZA727473B (bg)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (de) * 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (de) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2810083A1 (de) 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
NZ584152A (en) 2007-09-14 2011-11-25 Ortho Mcneil Janssen Pharm 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
NZ584148A (en) 2007-09-14 2011-05-27 Ortho Mcneil Janssen Pharm 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
KR101520086B1 (ko) 2007-09-14 2015-05-14 얀센 파마슈티칼스 인코포레이티드 1´,3´-이치환된-4-페닐-3,4,5,6-테트라히드로-2h,1´h-[1,4´]비피리디닐-2´-온
JP5433582B2 (ja) 2007-11-14 2014-03-05 ジャンセン ファーマシューティカルズ, インコーポレイテッド. イミダゾ[1,2−a]ピリジン誘導体およびmGluR2受容体の正のアロステリック調節因子としてのその使用
RU2510396C2 (ru) 2008-09-02 2014-03-27 Янссен Фармасьютикалз, Инк. 3-азабицикло[3.1.0]гексильные производные в качестве модуляторов метаботропных глутаматных рецепторов
AU2009304293B2 (en) 2008-10-16 2012-04-26 Addex Pharma S.A. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
AU2009319387B2 (en) 2008-11-28 2012-05-10 Addex Pharma S.A. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
US8937060B2 (en) 2009-05-12 2015-01-20 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
AU2010246607B2 (en) 2009-05-12 2012-09-27 Addex Pharma S.A. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
WO2010142241A1 (en) * 2009-06-10 2010-12-16 Techfields Biochem Co., Ltd. High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR102414246B1 (ko) 2014-01-21 2022-06-27 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
HUE053734T2 (hu) 2014-01-21 2021-07-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (de) * 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline

Also Published As

Publication number Publication date
IE37123B1 (en) 1977-05-11
RO60670A (bg) 1976-10-15
AT320152B (de) 1975-01-27
SU527139A3 (ru) 1976-08-30
AR195805A1 (es) 1973-11-09
JPS57843B2 (bg) 1982-01-08
YU264072A (en) 1982-06-18
BG20813A3 (bg) 1975-12-20
DK134992C (da) 1977-07-18
GB1392849A (en) 1975-04-30
IL40628A0 (en) 1972-12-29
FI56839C (fi) 1980-04-10
ES407851A1 (es) 1975-10-01
DE2152967B2 (de) 1981-02-19
CS188883B2 (en) 1979-03-30
DE2152967A1 (de) 1973-05-03
CY947A (en) 1978-06-23
JPS4849787A (bg) 1973-07-13
EG10826A (en) 1976-12-31
CH579089A5 (bg) 1976-08-31
JPS55391B2 (bg) 1980-01-08
DE2152967C3 (de) 1981-11-19
NO143909B (no) 1981-01-26
KE2824A (en) 1978-04-07
SE412236B (sv) 1980-02-25
RO63066A (fr) 1978-06-15
DD106044B3 (de) 1990-07-18
PL89056B1 (bg) 1976-10-30
HU167986B (bg) 1976-02-28
AU4806472A (en) 1974-04-26
HK18578A (en) 1978-04-14
PH9893A (en) 1976-06-08
FR2157908A1 (bg) 1973-06-08
IL40628A (en) 1976-08-31
BE790440A (bg) 1973-04-24
FR2157908B1 (bg) 1976-03-19
ZA727473B (en) 1973-07-25
NO143909C (no) 1981-05-06
CA1019323A (en) 1977-10-18
IE37123L (en) 1973-04-23
LU66332A1 (bg) 1973-01-23
DD106044A5 (bg) 1974-05-20
DK134992B (da) 1977-02-21
JPS4849910A (bg) 1973-07-14
FI56839B (fi) 1979-12-31
PL93574B1 (bg) 1977-06-30

Similar Documents

Publication Publication Date Title
BG20813A3 (bg) Метод за получаване на заместени бензилпеницилини
BG20806A3 (bg) Метод за получаване на субституирани азапуринони
BG21027A3 (bg) Метод за получаване на изотиоцианобензазоли
IT968463B (it) Metodo per produrre pullulano
BG19376A3 (bg) Метод за получаване на заместени бензилпеницилин
BG20358A3 (bg) Метод за получаване на пиримидинил-пиразолоново производни
BG26666A3 (bg) Метод за получаване на капролактам
BG19593A3 (bg) Метод за получаване на субституирани 3-/-2-/4- фенил-1- пиперазини
BG20777A3 (bg) Метод за получаване на 4- /-4 -бифенилил/-1-бутанол
BG20562A3 (bg) Метод за получаване на халогенацетанилиди
BG18858A3 (bg) Метод за получаване на 1-фенокси-2-хидрокси-3- хидроксиалкил аминопропани
BG21016A3 (bg) Метод за получаване на фениламиноалкани
BG20788A3 (bg) Метод за получаване на тиокарбамиди
BG19138A3 (bg) Метод за получаване на фенилкарбамиди
BG22836A3 (bg) Метод за получаване на 7-аминоцефалоспоринова киселина
BG19149A3 (bg) Метод за получаване на 1-алкилен-2-аминометил-пиролидин
BG23008A3 (bg) Метод за получаване на 7-аминодезацетоксицефалоспоринов естер
BG20555A3 (bg) Метод за получаване на n-изопропил-анилин
BG17979A3 (bg) Метод за получаване на дез- фенила- ланин в1- инсулин
BG18415A3 (bg) Метод за получаване на n- винилхинолони
SU493957A3 (ru) Способ получени замещенных фенилэтаноламинов
BG19156A3 (bg) Метод за получаване на инденпиридинови производни
BG20798A3 (bg) Метод за получаване на сулфониламинопиримидини
SU420643A3 (ru) Способ получения трикарбоцианиновыхкрасителей
BG23752A3 (bg) Метод за получаване на субституирани азапуринони